Enhance reliability, reduce risk, and optimize lifecycle management.
"Fourier 80" is a product that is easy to manage throughout its lifecycle due to its adherence to universal NMR principles. Thanks to the universality and specificity of NMR, robust identification tests can be conducted with this product, eliminating the need for standard substance management. Measurements can be taken without prior preparation of the device through a non-contact procedure, thereby preventing the risk of cross-contamination and allowing for efficient quality control testing. A simple quantitative assay design can be achieved in just a few steps, from raw materials to the final product. [Features] - Simplification of system qualification evaluation and monitoring - Increased efficiency in method validation - Clear risk assessment - Standardization of procedures as a platform *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
【Other Features】 ■ No bias ■ Direct analysis of uncertainty ■ No need for identical standard materials ■ Simplification of exploration *For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Bruker Biospin Group designs, manufactures, and sells instruments based on magnetic resonance technology, including world-class nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) spectrometers. They also develop preclinical imaging systems with single and multiple modes using magnetic resonance imaging (MRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), computed tomography (CT), and magnetic particle imaging (MPI) technologies. Bruker Biospin provides the unique capabilities of NMR to determine the structure, dynamics, and functions of specific molecules to customers in academic research institutions, government agencies, industry, and pharmaceutical companies. In particular, applications in structural proteomics, drug discovery, pharmaceutical and biotechnology research and production, and food and materials science are expected to be promising.
![[Analysis Case] C0677](https://image.mono.ipros.com/public/product/image/e3e/2000764270/IPROS94402830236761809628.png?w=280&h=280)
